Khadija Saeed

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Coca-Cola Stock (KO) Outlook: CEO Transition, Dividend Week, Analyst Targets — Updated Dec. 12, 2025

Coca-Cola Stock (KO) Outlook: CEO Transition, Dividend Week, Analyst Targets — Updated Dec. 12, 2025

Coca-Cola stock ended the week near the $70 level after a choppy stretch of trading that included a sharp one-day dip and a strong Friday rebound. Investors are weighing a leadership transition set for 2026, the company’s steady “defensive” profile, and the next set of catalysts: a dividend payment on Monday and a data-heavy U.S. economic calendar that could influence interest rates—and by extension the appeal of dividend-focused stocks like KO. StockAnalysis+2StockAnalysis+2
14 December 2025
Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income Corporation closed this week with investors balancing two fresh, shareholder-friendly headlines—a new dividend increase and a headline-grabbing $800 million preferred equity investment in CityCenter Las Vegas—against the bigger force that still tends to steer net-lease REITs: interest rates and bond yields. StockAnalysis
Altria (MO) Stock Update: New Dividend, CEO Succession, and What to Watch Next Week (Updated Dec. 12, 2025)

Altria (MO) Stock Update: New Dividend, CEO Succession, and What to Watch Next Week (Updated Dec. 12, 2025)

Altria Group, Inc. ended Friday, Dec. 12, at $58.75, extending a string of modest daily gains and leaving the stock up roughly ~1%–1.3% over the last five sessions—a steady week for a high-yield, defensive name as investors digested two company-specific headlines: a CEO succession announcement and a fresh quarterly dividend declaration. StockAnalysis+2Reuters+2
13 December 2025
Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike, Inc. heads into next week with its biggest near-term catalyst on the calendar: fiscal Q2 2026 earnings on Thursday, Dec. 18. Nike Investor Relations After a volatile start to the week, Nike shares finished Friday at $67.47 and ended the week up about 2.4% versus last Friday’s close. StockAnalysis
McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

McKesson Corporation ended the week on a steadier footing after an early-week dip, closing Friday at $813.80. The stock is still down roughly 9% from its late-November 52‑week high, but it remains one of healthcare’s stronger large-cap performers in 2025 as investors continue to reward its specialty-drug and oncology momentum, capital returns, and portfolio reshaping narrative. MarketWatch+1
13 December 2025
HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

Updated: December 12, 2025HCA Healthcare, Inc. closed Friday at $484.77, finishing the week essentially flat—but not quiet. A sharp midweek drop and quick rebound put policy risk, reimbursement headlines, and year-end positioning back in the spotlight for America’s largest for-profit hospital operator. StockAnalysis+2MarketWatch+2
13 December 2025
Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Starbucks stock ended the week on a steadier note after a choppy stretch that included a sharp early-week dip and a rebound into Friday’s close. Heading into next week, investors are weighing three near-term forces: labor headlines, operational initiatives tied to CEO Brian Niccol’s “Back to Starbucks” turnaround, and macro data that can swing consumer-facing names.
Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals Incorporated finished Friday at $452.04, extending a late-week rebound after a choppy start to the week. The stock’s intraday range on Friday stretched from $442.94 to $455.99 on volume of about 1.62 million shares, as biotech investors weighed fresh pipeline headlines, Wall Street price-target moves, and a shifting macro backdrop following the Federal Reserve’s latest rate decision. MarketWatch+1
Parker-Hannifin (PH) Stock: Deal-Financing Update, This Week’s New Highs, and the Week Ahead (Updated Dec. 12, 2025)

Parker-Hannifin (PH) Stock: Deal-Financing Update, This Week’s New Highs, and the Week Ahead (Updated Dec. 12, 2025)

Parker-Hannifin Corporation wrapped up a volatile week still sitting near fresh highs after a rapid run-up earlier in the week. Shares closed Friday at $884.87, down 1.59% on the day, after setting a new 52-week high of $901.31 on Dec. 11. Trading volume on Dec. 12 came in below the stock’s 50-day average, suggesting a bout of profit-taking rather than a broad rush for the exits. MarketWatch
13 December 2025
KKR Stock (NYSE: KKR) Update: This Week’s Rally, Today’s Pullback, Latest News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

KKR Stock (NYSE: KKR) Update: This Week’s Rally, Today’s Pullback, Latest News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Updated: December 12, 2025KKR & Co. Inc. wrapped up a volatile but ultimately positive week for shareholders, finishing Friday with a sharp pullback that snapped a powerful multi-day rally. The move comes as investors digest a rush of company headlines—from a major European telecom exit update to fresh Wall Street coverage and more AI- and infrastructure-linked deal flow—against the backdrop of the Federal Reserve’s latest rate cut and a data-heavy week ahead.
13 December 2025
1 777 778 779 780 781 891
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

CACI International

NYSE: CACI 95 / 100
#2 BUY

Constellation Energy

NASDAQ: CEG 93 / 100
#3 BUY

AerCap

NYSE: AER 91 / 100
#4 BUY ON PULLBACK

Motorola Solutions

NYSE: MSI 89 / 100
#5 ACCUMULATE

Walt Disney

NYSE: DIS 87 / 100
View full portfolio
Editorial model selection. Not personalised advice.